Use of primary human fetal chondroblast culture for xenotransplantation into rat articular cartilage defect.

The possibility of xenotransplantation of human fetal chondroblasts was studied. Filling of the rat articular cartilage defect with a tissue-engineering construction based on primary culture of human fetal chondroblasts and chitosan gel caused no immune rejection over 60 days and provided the formation of organotypical regenerate due to proliferation and differentiation of donor fetal chondroblasts and their integration in the recipient cartilage tissue.

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.

Optimal conditions are determined for growing cold-adapted reassortant strains of a live influenza vaccine in MDCK cell line cultivated in a fermenter with a serum-free medium and microcarriers. The studied MDCK cell line meet all national and WHO requirements for the finite cell lines used for the production of biological preparations. CA reassortant vaccine strains grown in such conditions which fully preserve its mutations and the mutations lead to amino acid substitution in all genome segments of the studied CA reassortants.

[Prospects of use human fetal fibroblasts in the treatment of various etiology wounds].

The investigations have demonstrated a high efficiency of the certified human fetal lung fibroblasts in the treatment of skin wounds of various etiology. For treatment, a fibroblast monolayer grown on a backing was applied to various types of wounds (burns frostbites, donor site suppurations) and in shin phlegmon. There was wound debrediment and rapid skin recovery.